Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Lippo Karawaci Tbk (LPKR.JK)
Tangerang, ID
PT Lippo Karawaci Tbk, an Indonesian conglomerate operating through its subsidiaries, specializes in comprehensive property development. Its operations are structured across three primary divisions: Real Estate Development, Real Estate Management & Services, and Fund Management/Investments. The Real Estate Development division is responsible for extensive real estate activities, encompassing urban planning, infrastructure creation, and the execution of expansive, integrated projects. These developments include residential condominiums, commercial and entertainment centers, office complexes, and facilities dedicated to healthcare and education. This segment also incorporates a food business and other strategic investments. The Real Estate Management & Services division focuses on the development and operation of shopping centers, hotels, recreational venues, and restaurants. Furthermore, it delivers essential services such as health and town management, water and sewage treatment, alongside transportation and maintenance solutions. The Fund Management/Investments segment primarily offers specialized management services. Beyond these core property offerings, the company engages in a vast array of complementary activities. These include financial, professional, scientific, and technical services; construction; various aspects of transportation and trading; comprehensive water, wastewater, waste management, and recycling solutions; parking and remediation services; and staffing provisions. A significant part of its portfolio also involves operating hospitals, clinics, health centers, polyclinics, and providing other related healthcare services. Its extended business interests span investments, printing, agriculture, gardening, workshop operations, pharmaceutical wholesale, mining, computer programming, diverse management consulting, hotel management, township development, asset management, home care, and air installation. As of December 31, 2021, Lippo Karawaci's extensive portfolio included 40 hospitals, 59 malls (comprising 49 leased and 10 strata-titled properties), and 10 hotels. Established in 1990 under its former name, PT Tunggal Reksakencana, the company maintains its headquarters in Tangerang, Indonesia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -4.17% | -15.85% | -34.91% | -24.18% | -18.82% | -18.82% | -25.00% | -57.93% | -91.22% | -71.77% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Real Estate - Services: +10.0%-22.1% Q1'26: -12.7% (vs Q1'25)
-
EPS growth Real Estate - Services: +28.6%-97.5% Q1'26: -36.8% (vs Q1'25)
-
FCF margin Real Estate - Services: +21.6%+0.1% Q1'26: -30.4% (vs Q1'25)
-
EBIT margin Real Estate - Services: +24.5%+6.9% Q1'26: +19.0% (vs Q1'25)
-
ROIC Real Estate - Services: +4.1%+1.3% Q1'26: +3.1% (vs Q1'25)
-
Share dilution Real Estate - Services: +0.0%+55.1% Q1'26: +55.1% (vs Q1'25)
-
Debt / EBITDA Real Estate - Services: 1.60×8.57× Q1'26: 5.40× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.70T
est: 9.79T (-11.1%)
|
10.32T
est: 10.21T (+1.1%)
|
10.90T
est: 11.29T (-3.5%)
|
12.28T
est: 12.47T (-1.5%)
|
12.18T
est: 12.69T (-4.1%)
|
11.81T
est: 11.97T (-1.3%)
|
16.14T
est: 14.22T (+13.5%)
|
14.67T
est: 13.74T (+6.8%)
|
16.85T
est: 16.83T (+0.1%)
|
11.35T
est: 11.13T (+2.0%)
|
8.84T
est: 9.15T (-3.3%)
|
9.30T
9.01T – 9.60T
+1.7% YoY
|
8.53T
7.94T – 9.12T
-8.3% YoY
|
7.64T
7.40T – 7.88T
-10.5% YoY
|
| EBITDA |
1.82T
est: 2.20T (-17.4%)
|
2.44T
est: 2.30T (+6.3%)
|
2.09T
est: 2.54T (-17.6%)
|
3.57T
est: 2.80T (+27.5%)
|
372.24B
est: 2.85T (-87.0%)
|
-5.53T
est: 2.69T (-305.6%)
|
3.85T
est: 3.20T (+20.6%)
|
1.49T
est: 3.09T (-51.8%)
|
4.25T
est: 5.79T (-26.6%)
|
21.32T
est: 3.83T (+457.1%)
|
1.12T
est: 3.15T (-64.2%)
|
3.20T
3.10T – 3.30T
+1.7% YoY
|
2.93T
2.73T – 3.14T
-8.3% YoY
|
2.63T
2.54T – 2.71T
-10.5% YoY
|
| EBIT |
1.55T
est: 1.29T (+19.7%)
|
1.88T
est: 1.35T (+39.2%)
|
1.38T
est: 1.49T (-7.2%)
|
2.75T
est: 1.64T (+67.5%)
|
-771.39B
est: 1.67T (-146.1%)
|
-7.47T
est: 1.58T (-572.8%)
|
1.49T
est: 1.88T (-20.3%)
|
87.76B
est: 1.81T (-95.2%)
|
3.10T
est: 4.55T (-31.9%)
|
20.59T
est: 3.01T (+584.4%)
|
612.49B
est: 2.47T (-75.2%)
|
2.52T
2.44T – 2.60T
+1.7% YoY
|
2.31T
2.15T – 2.47T
-8.3% YoY
|
2.07T
2.00T – 2.13T
-10.5% YoY
|
| Net Income |
535.39B
est: 1.64T (-67.4%)
|
882.41B
est: 1.53T (-42.2%)
|
614.17B
est: 1.54T (-60.0%)
|
695.15B
est: 1.42T (-51.0%)
|
-2.06T
est: -1.20T (-71.8%)
|
-9.64T
est: -454.15B (-2,022.0%)
|
-1.62T
est: 190.83B (-950.6%)
|
-2.33T
est: -600.83B (-287.4%)
|
50.14B
est: 18.79T (-99.7%)
|
18.75T
est: 20.52T (-8.6%)
|
469.54B
est: 407.17B (+15.3%)
|
772.10B
765.05B – 830.73B
+89.6% YoY
|
917.50B
728.29B – 1.38T
+18.8% YoY
|
1.34T
1.29T – 1.40T
+46.4% YoY
|
| SGA |
922.87B
est: 914.31B (+0.9%)
|
958.15B
est: 953.77B (+0.5%)
|
1.07T
est: 1.05T (+1.2%)
|
1.14T
est: 1.16T (-2.0%)
|
1.22T
est: 1.19T (+3.3%)
|
1.12T
est: 1.12T (+0.0%)
|
1.43T
est: 1.33T (+7.8%)
|
1.42T
est: 1.28T (+10.5%)
|
1.52T
est: 1.96T (-22.5%)
|
1.10T
est: 1.29T (-14.8%)
|
1.85T
est: 1.06T (+73.7%)
|
1.08T
1.05T – 1.12T
+1.7% YoY
|
991.32B
923.03B – 1.06T
-8.3% YoY
|
887.64B
859.54B – 915.75B
-10.5% YoY
|
| EPS |
30.75
est: 35.98 (-14.5%)
|
30.75
est: 33.39 (-7.9%)
|
21.40
est: 33.62 (-36.3%)
|
24.23
est: 31.08 (-22.0%)
|
-45.56
est: -26.26 (-73.5%)
|
-136.43
est: -9.94 (-1,272.5%)
|
-22.93
est: 4.18 (-649.0%)
|
-50.94
est: -13.15 (-287.4%)
|
1.10
est: 265.10 (-99.6%)
|
264.49
est: 289.50 (-8.6%)
|
6.62
est: 5.76 (+14.9%)
|
11.26
10.79 – 11.72
+95.4% YoY
|
14.84
10.28 – 19.41
+31.8% YoY
|
19.00
18.22 – 19.78
+28.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 5/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 5/5 |
| 2026-05-25 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 5/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 5/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 5/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 2/5 | 5/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-15 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-14 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-13 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-10 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Agus Arismunandar | Head of Investor relations, Corporate Secretary & Director | — | male |
| Alwi Rubidium Sjaaf | Chief Development Officer | — | male |
| Caroline Riady | Vice President Director & Chief Executive Officer of PT Siloam International Hospitals Tbk | — | female |
| Danang Kemayan Jati | Head of Corporate Communications | — | — |
| Dominique Dion Leswara | Chief Human Resources & Administration Officer and Director | — | male |
| Ernest Alto | Head of Internal Audit | — | male |
| Fendi Santoso | CFO & Director | — | male |
| Jopy Rusli | Chief Marketing Officer | — | male |
| Marlo Budiman | President Director | — | male |
| Surya Tatang | Chief Investment Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LPKR.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
